Botulinum toxin A (BOTOX®) in neurogenic urinary incontinence: Results from a multi-centre randomised, controlled trial
Schurch B1, de Sèze M2, Denys P3, Chartier-Kastler E4, Ismael S5, Haab F6, Everaert K7, Keppenne V8, Plante P9, Perrouin-Verbe B10, Kumar C11, Fraczek S11 1. Univeritatsklinik Balgrist, 2. Hôpital Pellegrin, 3. Hôpital Raymond Poincaré, 4. Group Hospitalier Pitié-Salpétriè, 5. Hôpital de Rothschild, 6. Hôpital Tenon, 7. Ghent University Hospital, 8. CHU Sart Tilman, 9. Hôpital Rangueil, 10. CHU Nantes, 11. Allergan Ltd
| Abstract 151 |
| Clinical Pharmacology and Overactivity - Blue Room:Chaired by Harold Drutz and Alan Wein
Scientific Podium Poster Session 16 |
| Friday 27th August 2004 |
| 15:32 - 15:40 |
|